Bright Uro Launches Glean Registry to Build AI-Driven Urodynamics Data Asset

New updates have been reported about Bright Uro.

Bright Uro has launched the Glean Registry, a real-world data initiative that aggregates de-identified clinical information from commercial use of its Glean Urodynamics System to accelerate understanding of lower urinary tract dysfunction and support development of AI- and ML-based diagnostic tools. The program is designed to create a comprehensive dataset across the spectrum of lower urinary tract conditions, positioning Bright Uro to enhance product development, strengthen clinical evidence, and deepen adoption among urology practices.

By capturing standardized, high-quality signals from its wireless, catheter-free Glean platform, Bright Uro aims to build what it expects will be the largest repository of urodynamics data and the backbone for its Urodynamic Intelligence platform, which will generate algorithms to aid interpretation of test results and potentially raise diagnostic accuracy and efficiency. Executives describe the registry as a key strategic asset that supports market leadership ambitions by embedding data science into the company’s core offering, improving the value proposition for clinicians treating overactive bladder, stress urinary incontinence, benign prostatic hyperplasia, and neurogenic bladder dysfunction.